2025 annual financial data
Sonoma Pharmaceuticals 2025 Net income growth
Direct answer
Net income growth was 28.5%.
Operating income was -3,710,000 USD and net income was -3,457,000 USD.
Operating cash flow was -88,000 USD.
Get free Sonoma Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,288,000 USD
- Operating income
- -3,710,000 USD
- Net income
- -3,457,000 USD
- Operating cash flow
- -88,000 USD